{"result": {"id": "7a579c9b-6b42-4567-8a7c-6fd5241d1489", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>TRICYCLIC ANTIDEPRESSANTS (TCAS)<|>ORGANIZATION<|>A class of antidepressant drugs including amitriptyline, clomipramine, and dosulepin, used for treating depression and anxiety\")  \n##  \n(\"entity\"<|>SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)<|>ORGANIZATION<|>A class of antidepressant drugs mentioned as being commonly used by pregnant women with severe depression\")  \n##  \n(\"entity\"<|>WITHDRAWAL SYNDROME<|>EVENT<|>A condition occurring in about 20% of patients when stopping or reducing antidepressant medication, with symptoms like flu-like symptoms and anxiety\")  \n##  \n(\"relationship\"<|>AMITRIPTYLINE<|>TRICYCLIC ANTIDEPRESSANTS (TCAS)<|>Amitriptyline belongs to the class of tricyclic antidepressants<|>9\")  \n##  \n(\"relationship\"<|>CLOMIPRAMINE<|>TRICYCLIC ANTIDEPRESSANTS (TCAS)<|>Clomipramine belongs to the class of tricyclic antidepressants<|>9\")  \n##  \n(\"relationship\"<|>DOSULEPIN<|>TRICYCLIC ANTIDEPRESSANTS (TCAS)<|>Dosulepin belongs to the class of tricyclic antidepressants<|>9\")  \n##  \n(\"relationship\"<|>WITHDRAWAL SYNDROME<|>TRICYCLIC ANTIDEPRESSANTS (TCAS)<|>Withdrawal syndrome can occur when stopping tricyclic antidepressants<|>7\")  \n##  \n(\"relationship\"<|>WITHDRAWAL SYNDROME<|>SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)<|>Withdrawal syndrome can occur when stopping SSRIs<|>7\")  \n##  \n(\"relationship\"<|>SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS)<|>PREGNANT WOMEN<|>SSRIs are the most commonly used antidepressants for pregnant women with severe depression<|>6\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558472, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 493, "prompt_tokens": 3430, "total_tokens": 3923, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3328}, "prompt_cache_hit_tokens": 3328, "prompt_cache_miss_tokens": 102}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 抗抑郁药\n\n湖南药事服务网\nhttp://www.hnysfww.com/\n\n　　中华全科医师杂志 2021 年 12 月第 20 卷第 12 期    Chin J Gen Pract, December 2021, Vol. 20, No. 12 表3  传统抗抑郁药和其他治疗抑郁症的药物使用说明［18］\n药名\t药理机制\t常用剂量\t治疗特点\t常见不良反应\t注意事项\n阿米替林\tTCAs\t50~250 mg/d\t对焦虑和抑郁 症状均有明 显效果\t心律失常 、体位性低血压 、口 干 、便秘 、排尿困难 、性功能 障碍、谵妄\t定期查心电图 ；监测血压 ；评 估其他可能导致不良反应 的躯体因素\n氯米帕明\tTCAs\t50~250 mg/d\t同阿米替林\t同阿米替林\t同阿米替林\n多塞平\tTCAs\t50~250 mg/d\t同阿米替林\t同阿米替林\t同阿米替林\n马普替林\t四环类\t50~225 mg/d\t同阿米替林\t同阿米替林\t同阿米替林\n氟哌噻吨美利曲辛片\t复方制剂\t1~3 片/d\t控制焦虑、改善 睡眠\t口干 、便秘 、肌阵挛 、镇静 、视 力模糊 、撤药反应\t缓慢减量\n圣·约翰草提取物片\t中成药\t1片/次、2~3次/d\t耐受性好\t少见\t用于轻中度抑郁症\n疏肝解郁胶囊\t中成药\t2粒/次、2次/d\t耐受性好\t少见\t用于轻中度抑郁症\n巴戟天寡糖胶囊\t中成药\t1~2粒/次、2次/d\t耐受性好；对性 功能有改善\t少见\t用于轻中度抑郁症\n\n\n注：TCAs 三环类抗抑郁药\n　　（4）撤药综合征：抗抑郁药的撤药综合征通常  出现在大约 20% 的患者中，在服用一段时间的药物  后停药或减药时发生 。几乎所有种类的抗抑郁药  都有可能发生撤药综合征，其发生与使用药物时间  较长，药物半衰期较短有关 。通常表现为流感样症  状、精神症状及神经系统症状（如焦虑、激越、失眠、 恶心、呕吐）等 。撤药综合征的症状可能被误诊为  病情复发。\n　　（5）妊娠期用药：关于妊娠或计划妊娠妇女是  否继续服用抗抑郁药物，需要权衡药物治疗对母亲  和胎儿的获益与不治疗的风险，并向患者及家属交  待清楚 。对症状较轻的患者给予健康教育、支持性  心理治疗即可；对轻度?中度抑郁症患者，可给予认  知行为治疗和人际心理治疗；对重度或有严重自杀  倾向的患者可以考虑抗抑郁药治疗，目前孕妇使用  最多的是 SSRIs 类药物 。研究显示 ，除\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>HUNAN PHARMACEUTICAL SERVICE NETWORK<|>ORGANIZATION<|>A website providing pharmaceutical services in Hunan, China, with information on antidepressant drugs and their usage\")  \n##  \n(\"entity\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>ORGANIZATION<|>A medical journal publishing research and guidelines on general practice, including antidepressant drug usage\")  \n##  \n(\"entity\"<|>AMITRIPTYLINE<|>ORGANIZATION<|>A tricyclic antidepressant (TCA) used for treating anxiety and depression, with common side effects like arrhythmia and dry mouth\")  \n##  \n(\"entity\"<|>CLOMIPRAMINE<|>ORGANIZATION<|>A tricyclic antidepressant (TCA) similar to amitriptyline, used for anxiety and depression\")  \n##  \n(\"entity\"<|>DOSULEPIN<|>ORGANIZATION<|>A tricyclic antidepressant (TCA) with effects and side effects similar to amitriptyline\")  \n##  \n(\"entity\"<|>MAPROTILINE<|>ORGANIZATION<|>A tetracyclic antidepressant used for treating depression, with effects similar to TCAs\")  \n##  \n(\"entity\"<|>FLUPENTIXOL/MELITRACEN<|>ORGANIZATION<|>A compound preparation used to control anxiety and improve sleep, with side effects like dry mouth and constipation\")  \n##  \n(\"entity\"<|>ST. JOHN'S WORT EXTRACT<|>ORGANIZATION<|>A traditional Chinese medicine used for mild to moderate depression, with good tolerance\")  \n##  \n(\"entity\"<|>SHUGAN JIEYU CAPSULE<|>ORGANIZATION<|>A traditional Chinese medicine capsule used for mild to moderate depression, with good tolerance\")  \n##  \n(\"entity\"<|>MORINDA OFFICINALIS OLIGOSACCHARIDE CAPSULE<|>ORGANIZATION<|>A traditional Chinese medicine capsule used for mild to moderate depression, with potential benefits for sexual function\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>AMITRIPTYLINE<|>The journal published guidelines on the usage of amitriptyline and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>CLOMIPRAMINE<|>The journal published guidelines on the usage of clomipramine and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>DOSULEPIN<|>The journal published guidelines on the usage of dosulepin and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>MAPROTILINE<|>The journal published guidelines on the usage of maprotiline and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>FLUPENTIXOL/MELITRACEN<|>The journal published guidelines on the usage of flupentixol/melitracen and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>ST. JOHN'S WORT EXTRACT<|>The journal published guidelines on the usage of St. John's Wort extract and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>SHUGAN JIEYU CAPSULE<|>The journal published guidelines on the usage of Shugan Jieyu capsule and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>MORINDA OFFICINALIS OLIGOSACCHARIDE CAPSULE<|>The journal published guidelines on the usage of Morinda officinalis oligosaccharide capsule and other antidepressants<|>6\")  \n##  \n(\"relationship\"<|>HUNAN PHARMACEUTICAL SERVICE NETWORK<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>The website may reference or host content from the journal regarding antidepressant usage<|>4\")  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_86d58b2dca417e5e08bd332f6aff78c1c8e07463a92b842d26b916790030af5e_v2"}